LHCGR and ovarian dysfunction: As it has been observed with the inactivating LHCGR mutations, there is in general a good correlation between residual activity exhibited by the mutant FSHRs and the spectrum of the clinical phenotype expressed by the patients bearing the mutation(s) [106,107,116], ranging from congenital, complete ovarian failure, to premature ovarian failure in adult life.